Inventor · disambiguated record
Peter Tontonoz
Also filed as: TONTONOZ PETER · TONTONOZ PETER J
7 granted patents·5 pending applications·224 citations·filing 1997–2019
86Inventor score
Files withSALK INST FOR BIOLOGICAL STUDI4DANA FARBER CANCER INST INC3TONTONOZ PETER J2IRM LLC1UNIV CALIFORNIA1
Top patents by PatentIndex Score
12 records- 0189US6242196B1Methods and pharmaceutical compositions for inhibiting tumor cell growthDANA FARBER CANCER INST INC·Filed 1997·Granted Jun 5, 2001·117 cites·35 claims
- 0287US8512964B2Targets for treatment of hypercholesterolemiaTONTONOZ PETER J·Filed 2009·Granted Aug 20, 2013·47 cites·10 claims
- 0371US6552055B2Methods and pharmaceutical compositions for inhibiting tumor cell growthDANA FARBER CANCER INST INC·Filed 1997·Granted Apr 22, 2003·44 cites·4 claims
- 0460US7635708B2Methods and pharmaceutical compositions for inhibiting tumor cell growthDANA FARBER CANCER INST INC·Filed 2002·Granted Dec 22, 2009·1 cites·27 claims
- 0551US2021255205A1Compositions and methods for treating metabolic diseaseUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 0650US2004162354A1Treatment of disease states which result from neoplastic cell proliferation using PPAR-gamma activators and compositions useful thereforSALK INST FOR BIOLOGICAL STUDI·Filed 2003·Application pending·0 cites
- 0746US6436993B1Use of RAR antagonists as modulators of hormone mediated processesSALK INST FOR BIOLOGICAL STUDI·Filed 1999·Granted Aug 20, 2002·9 cites·14 claims
- 0843US6646008B1Treatment of disease states which result from neoplastic cell proliferation using PPAR-γ activators and compositions useful thereforSALK INST FOR BIOLOGICAL STUDI·Filed 1997·Granted Nov 11, 2003·6 cites·12 claims
- 0943US2005036992A1Novel use of liver X receptor agonistsIRM LLC·Filed 2003·Application pending·0 cites
- 1042US2014072580A1Novel targets for treatment of hypercholesterolemiaTONTONOZ PETER J·Filed 2013·Application pending·0 cites
- 1140US2004259948A1Reciprocal regulation of inflammation and lipid metabolism by liver X receptorsFiled 2004·Application pending·0 cites
- 1230US6586455B1Treatment of liposarcomas using a combination of thiazolidinediones and retinoid X receptor selective agonistsSALK INST FOR BIOLOGICAL STUDI·Filed 1997·Granted Jul 1, 2003·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Peter Tontonoz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →